calphostin c Search Results


calphostin c  (Tocris)
92
Tocris calphostin c
Calphostin C, supplied by Tocris, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/calphostin+c/Calphostin+C/pmc06747167-128-44-48
Average 92 stars, based on 1 article reviews
calphostin c - by Bioz Stars, 2026-09
92/100 stars
  Buy from Supplier
calphostin c  (Santa Cruz Biotechnology)
92
Santa Cruz Biotechnology calphostin c
Calphostin C, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/calphostin+c/Calphostin+C/pmc04767628-125-11-13
Average 92 stars, based on 1 article reviews
calphostin c - by Bioz Stars, 2026-09
92/100 stars
  Buy from Supplier
calphostin c  (MedChemExpress)
94
MedChemExpress calphostin c
Calphostin C, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/calphostin+c/Calphostin+C/pm38545938__ja4c01173_si_001-77-9-11
Average 94 stars, based on 1 article reviews
calphostin c - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier
calphostin c  (LKT Laboratories)
85
LKT Laboratories calphostin c
Calphostin C, supplied by LKT Laboratories, used in various techniques. Bioz Stars score: 85/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/calphostin+c/Calphostin+C/10__1091_slash_mbc__e12___11___0829-246-0-5
Average 85 stars, based on 1 article reviews
calphostin c - by Bioz Stars, 2026-09
85/100 stars
  Buy from Supplier
calphostin c  (Biosynth Carbosynth)
90
Biosynth Carbosynth calphostin c
Calphostin C, supplied by Biosynth Carbosynth, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/calphostin+c/Calphostin+C/pmc06725301-105-43-38
Average 90 stars, based on 1 article reviews
calphostin c - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
staurosporin  (Kyowa Medex Co Ltd)
90
Kyowa Medex Co Ltd staurosporin
Staurosporin, supplied by Kyowa Medex Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/calphostin+c/calphostin+c/pm09287315-57-5-8
Average 90 stars, based on 1 article reviews
staurosporin - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
calphostin c (pkc inhibitor)  (Biomol GmbH)
90
Biomol GmbH calphostin c (pkc inhibitor)
Calphostin C (Pkc Inhibitor), supplied by Biomol GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/calphostin+c/calphostin+c/pm10377043-54-0-27
Average 90 stars, based on 1 article reviews
calphostin c (pkc inhibitor) - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
calphostin c  (LC Laboratories)
90
LC Laboratories calphostin c
Calphostin C, supplied by LC Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/calphostin+c/calphostin+c/pm08702671-62-0-10
Average 90 stars, based on 1 article reviews
calphostin c - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
calphostin c calpc  (Merck KGaA)
90
Merck KGaA calphostin c calpc
Calphostin C Calpc, supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/calphostin+c/calphostin+c/pmc03576123-48-0-24
Average 90 stars, based on 1 article reviews
calphostin c calpc - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
calphostin c  (Enzo Biochem)
90
Enzo Biochem calphostin c
IFN-γ increased mIPSC frequencies when amplitude augmentation was suppressed by postsynaptic PKC inhibition via calphostin C. (A) Example traces of mIPSCs recorded under postsynaptic intracellular application of PKC inhibitor <t>Calphostin</t> <t>C</t> (100 nM) before ( black ) and with IFN-γ ( green ). (B) Under intracellular PKC inhibition, IFN-γ, bath applied for 25.0 ± 1.0 min, increased mIPSC frequency and shifted IEI probability distribution toward shorter IEIs ( p < 0.0001, Kolmogorov–Smirnov test, ctrl = 2,254 IEIs vs. IFN-γ = 3,359 IEIs, 8 recordings, N = 2). Mean amplitudes remained comparable, however, amplitude probability distribution was slightly shifted toward lower amplitudes (below 80%), as well as higher amplitudes (above 90%) ( p < 0.0001, Kolmogorov–Smirnov test, ctrl = 2,270 events vs. IFN-γ = 3,375 events, 8 recordings, N = 2). Series resistance slightly increased from R s CalC ctrl = 15.4 ± 1.9 MΩ to R s CalC IFN_–γ = 17.5 ± 2.2 MΩ ( p = 0.001, paired t -test, n = 8, N = 2), holding current slightly decreased from −196.9 ± 27.1 pA to −121.1 ± 11.2 pA ( p = 0.02, paired t -test, n = 8, N = 2). * p < 0.05.
Calphostin C, supplied by Enzo Biochem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/calphostin+c/calphostin+c/pmc09401097-53-0-2
Average 90 stars, based on 1 article reviews
calphostin c - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
calphostin c  (Funakoshi ltd)
90
Funakoshi ltd calphostin c
IFN-γ increased mIPSC frequencies when amplitude augmentation was suppressed by postsynaptic PKC inhibition via calphostin C. (A) Example traces of mIPSCs recorded under postsynaptic intracellular application of PKC inhibitor <t>Calphostin</t> <t>C</t> (100 nM) before ( black ) and with IFN-γ ( green ). (B) Under intracellular PKC inhibition, IFN-γ, bath applied for 25.0 ± 1.0 min, increased mIPSC frequency and shifted IEI probability distribution toward shorter IEIs ( p < 0.0001, Kolmogorov–Smirnov test, ctrl = 2,254 IEIs vs. IFN-γ = 3,359 IEIs, 8 recordings, N = 2). Mean amplitudes remained comparable, however, amplitude probability distribution was slightly shifted toward lower amplitudes (below 80%), as well as higher amplitudes (above 90%) ( p < 0.0001, Kolmogorov–Smirnov test, ctrl = 2,270 events vs. IFN-γ = 3,375 events, 8 recordings, N = 2). Series resistance slightly increased from R s CalC ctrl = 15.4 ± 1.9 MΩ to R s CalC IFN_–γ = 17.5 ± 2.2 MΩ ( p = 0.001, paired t -test, n = 8, N = 2), holding current slightly decreased from −196.9 ± 27.1 pA to −121.1 ± 11.2 pA ( p = 0.02, paired t -test, n = 8, N = 2). * p < 0.05.
Calphostin C, supplied by Funakoshi ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/calphostin+c/calphostin+c/pm12943527-50-0-5
Average 90 stars, based on 1 article reviews
calphostin c - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results


IFN-γ increased mIPSC frequencies when amplitude augmentation was suppressed by postsynaptic PKC inhibition via calphostin C. (A) Example traces of mIPSCs recorded under postsynaptic intracellular application of PKC inhibitor Calphostin C (100 nM) before ( black ) and with IFN-γ ( green ). (B) Under intracellular PKC inhibition, IFN-γ, bath applied for 25.0 ± 1.0 min, increased mIPSC frequency and shifted IEI probability distribution toward shorter IEIs ( p < 0.0001, Kolmogorov–Smirnov test, ctrl = 2,254 IEIs vs. IFN-γ = 3,359 IEIs, 8 recordings, N = 2). Mean amplitudes remained comparable, however, amplitude probability distribution was slightly shifted toward lower amplitudes (below 80%), as well as higher amplitudes (above 90%) ( p < 0.0001, Kolmogorov–Smirnov test, ctrl = 2,270 events vs. IFN-γ = 3,375 events, 8 recordings, N = 2). Series resistance slightly increased from R s CalC ctrl = 15.4 ± 1.9 MΩ to R s CalC IFN_–γ = 17.5 ± 2.2 MΩ ( p = 0.001, paired t -test, n = 8, N = 2), holding current slightly decreased from −196.9 ± 27.1 pA to −121.1 ± 11.2 pA ( p = 0.02, paired t -test, n = 8, N = 2). * p < 0.05.

Journal: Frontiers in Cellular Neuroscience

Article Title: Interferon-γ augments GABA release in the developing neocortex via nitric oxide synthase/soluble guanylate cyclase and constrains network activity

doi: 10.3389/fncel.2022.913299

Figure Lengend Snippet: IFN-γ increased mIPSC frequencies when amplitude augmentation was suppressed by postsynaptic PKC inhibition via calphostin C. (A) Example traces of mIPSCs recorded under postsynaptic intracellular application of PKC inhibitor Calphostin C (100 nM) before ( black ) and with IFN-γ ( green ). (B) Under intracellular PKC inhibition, IFN-γ, bath applied for 25.0 ± 1.0 min, increased mIPSC frequency and shifted IEI probability distribution toward shorter IEIs ( p < 0.0001, Kolmogorov–Smirnov test, ctrl = 2,254 IEIs vs. IFN-γ = 3,359 IEIs, 8 recordings, N = 2). Mean amplitudes remained comparable, however, amplitude probability distribution was slightly shifted toward lower amplitudes (below 80%), as well as higher amplitudes (above 90%) ( p < 0.0001, Kolmogorov–Smirnov test, ctrl = 2,270 events vs. IFN-γ = 3,375 events, 8 recordings, N = 2). Series resistance slightly increased from R s CalC ctrl = 15.4 ± 1.9 MΩ to R s CalC IFN_–γ = 17.5 ± 2.2 MΩ ( p = 0.001, paired t -test, n = 8, N = 2), holding current slightly decreased from −196.9 ± 27.1 pA to −121.1 ± 11.2 pA ( p = 0.02, paired t -test, n = 8, N = 2). * p < 0.05.

Article Snippet: Calphostin C (Enzo Life Sciences, NY, United States) was dissolved in DMSO at 1 mM and aliquoted to working sizes.

Techniques: Inhibition